Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Love Lifesciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Love Lifesciences

Love Lifesciences

Pre-Seed

Love Lifesciences: Innovating injection safety with single-use and multi-dose devices for optimal medication adherence.

HQ
Overland Park, KS, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Love Lifesciences is dedicated to enhancing medication administration and adherence through innovative medical devices. The company offers two primary products: UniPen, a single-use injection device aimed at improving the patient injection experience while reducing financial and time burdens for pharmaceutical integration, and MultiPen, a multi-dose injection device designed to provide time-gated access to injectables, preventing medication over or underdosing. Their mission focuses on ensuring all patients "love life" by improving injection safety and adherence.

Love Lifesciences has made significant strides in the medical device industry, particularly in the realm of injection safety. Their products address critical issues of medication non-adherence, which is a major factor in hospitalizations and lost revenue for global pharma. By providing solutions that enhance the patient experience and ensure proper dosing, Love Lifesciences contributes to better health outcomes and economic savings. Their impact is evident in the improved adherence rates and the reduced burden on healthcare systems.

Love Lifesciences - Similar Companies

Diavibe logo

Diavibe

Portal Instruments logo

Portal Instruments

Genixus logo

Genixus

Solution Medical logo

Solution Medical

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Linear Health Sciences logo

Linear Health Sciences

linearsciences.com

Pocket Clinic logo

Pocket Clinic

pocketclinic.life

Ezalife logo

Ezalife

ezalife.com

DoseCue logo

DoseCue

AdhereTech logo

AdhereTech

adheretech.com

Infused Medical Technology logo

Infused Medical Technology

Lineus Medical logo

Lineus Medical

lineusmed.com

Wulou Labs logo

Wulou Labs

Omnipulse Biosciences logo

Omnipulse Biosciences

ApiJect Systems logo

ApiJect Systems

apiject.com

Love Lifesciences - Quick Facts

Who are Love Lifesciences' competitors?

Companies similar to Love Lifesciences include Diavibe, Portal Instruments, Genixus and Solution Medical.

When was Love Lifesciences founded?

Love Lifesciences was founded in 2020.

Where is Love Lifesciences' headquarters located?

Love Lifesciences' headquarters is located in Overland Park, KS, US.

When was Love Lifesciences' last funding round?

Love Lifesciences' most recent funding round was for $1M (USD) in November 2022.

How much has Love Lifesciences raised to-date?

As of Nov 2, 2022, Love Lifesciences has raised a total of $1.1M (USD).

How many employees does Love Lifesciences have?

Love Lifesciences has 3 employees as of Feb 5, 2024.

Love Lifesciences - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified